Does GEMCITABINE Cause Neoplasm recurrence? 65 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 65 reports of Neoplasm recurrence have been filed in association with GEMCITABINE (Gemcitabine). This represents 0.2% of all adverse event reports for GEMCITABINE.
65
Reports of Neoplasm recurrence with GEMCITABINE
0.2%
of all GEMCITABINE reports
11
Deaths
4
Hospitalizations
How Dangerous Is Neoplasm recurrence From GEMCITABINE?
Of the 65 reports, 11 (16.9%) resulted in death, 4 (6.2%) required hospitalization, and 21 (32.3%) were considered life-threatening.
Is Neoplasm recurrence Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for GEMCITABINE. However, 65 reports have been filed with the FAERS database.
What Other Side Effects Does GEMCITABINE Cause?
Off label use (3,319)
Disease progression (3,123)
Thrombocytopenia (2,320)
Drug ineffective (2,003)
Malignant neoplasm progression (1,962)
Neutropenia (1,892)
Anaemia (1,745)
Pyrexia (1,511)
Nausea (1,336)
Myelosuppression (1,197)
What Other Drugs Cause Neoplasm recurrence?
CYCLOPHOSPHAMIDE (293)
PALBOCICLIB (248)
DOXORUBICIN (240)
VINCRISTINE (239)
CYTARABINE (223)
METHOTREXATE (198)
CARBOPLATIN (170)
RITUXIMAB (163)
ETOPOSIDE (156)
PREDNISONE (144)
Which GEMCITABINE Alternatives Have Lower Neoplasm recurrence Risk?
GEMCITABINE vs GEMCITABINE\GEMCITABINE
GEMCITABINE vs GEMFIBROZIL
GEMCITABINE vs GEMTUZUMAB OZOGAMICIN
GEMCITABINE vs GEMZAR
GEMCITABINE vs GENTAMICIN